Abstract
Objectives:
Survival of no-touch aorta, total arterial off-pump CABG (OPCAB) with LIMA - radial artery Y-graft in 2004 - 2021 for all-comers for isolated CABG regardless of preoperative factors.
Patients and methods:
All patients with OPCAB no-touch aorta total arterial LIMA- RA Y-graft surgeries performed between 2004 and 2021 without any concomitant interventions were included. OPCAB was performed by a team of experienced surgeons. For 5 year survival times, Kaplan-Meier test and Cox regression were used. Patients were categorised into 5 age groups (<50 y.o.;50-59;60-69; 70-79; >80 years).
Results:
2174 patients were included. Median follow-up time was 3266 days. Mean number of grafts was 3,7 with little variation between age groups ranging from 3.6 to 3.8 (p=0.09), respectively. The 5 year survival probability was 90% (n=1767) and ranged between age groups from 98% to 65% (log rank: p=<0.0001). A Cox regression model observed that sex, age, NYHA class>1, CCS class IV, left ventricular ejection fraction, previous stroke, diabetes, PAD, chronic lung disease, EuroSCORE I (log) were potential predictors for long-term mortality.
Conclusion:
This study shows that total arterial no-touch aorta LIMA-RA Y-graft OPCAB as regular practice for all patients, regardless of age, is safe and effective. Our findings underline the strength of experience in a total arterial treatment strategy. Further research should identify risk factors influencing other outcomes after revascularization ensuring optimal outcomes across diverse patient populations.
Survival of no-touch aorta, total arterial off-pump CABG (OPCAB) with LIMA - radial artery Y-graft in 2004 - 2021 for all-comers for isolated CABG regardless of preoperative factors.
Patients and methods:
All patients with OPCAB no-touch aorta total arterial LIMA- RA Y-graft surgeries performed between 2004 and 2021 without any concomitant interventions were included. OPCAB was performed by a team of experienced surgeons. For 5 year survival times, Kaplan-Meier test and Cox regression were used. Patients were categorised into 5 age groups (<50 y.o.;50-59;60-69; 70-79; >80 years).
Results:
2174 patients were included. Median follow-up time was 3266 days. Mean number of grafts was 3,7 with little variation between age groups ranging from 3.6 to 3.8 (p=0.09), respectively. The 5 year survival probability was 90% (n=1767) and ranged between age groups from 98% to 65% (log rank: p=<0.0001). A Cox regression model observed that sex, age, NYHA class>1, CCS class IV, left ventricular ejection fraction, previous stroke, diabetes, PAD, chronic lung disease, EuroSCORE I (log) were potential predictors for long-term mortality.
Conclusion:
This study shows that total arterial no-touch aorta LIMA-RA Y-graft OPCAB as regular practice for all patients, regardless of age, is safe and effective. Our findings underline the strength of experience in a total arterial treatment strategy. Further research should identify risk factors influencing other outcomes after revascularization ensuring optimal outcomes across diverse patient populations.
| Original language | English |
|---|---|
| Publication status | Published - 17 Mar 2025 |
| Event | Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland , SCTS 2025 - Edinburgh International Conference Centre, Edinburgh, United Kingdom Duration: 16 Mar 2025 → 18 Mar 2025 https://scts.org/scts_annual_meeting/previous_meetings.aspx |
Conference
| Conference | Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland , SCTS 2025 |
|---|---|
| Abbreviated title | SCTS 2025 |
| Country/Territory | United Kingdom |
| City | Edinburgh |
| Period | 16/03/25 → 18/03/25 |
| Internet address |
Fingerprint
Dive into the research topics of 'No-touch aorta off-pump LIMA-radial Y-graft CABG: A safe strategy for all-comers: Long term follow up of a preferred treatment approach'. Together they form a unique fingerprint.Research output
- 1 Article
-
No-Touch Aorta Off-Pump LIMA-Radial Artery Y-Graft CABG as a Safe Strategy for All-Comers: Long-Term Survival
Plonek, T., Mendyka, D. & Halfwerk, F. R., 9 Jul 2025, In: Journal of Clinical Medicine. 14, 14, 4878.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile38 Downloads (Pure)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver